MICA and MICB overexpression in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 36, Issue 1, 2007, Pages 43-47

  Liu, Chung Ji ^a,b,c   Lui, Man Tin ^a,d   Chen, Hsin Lan ^a   Lin, Shu Chun ^a   Chang, Kuo Wei ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c Nursing   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

MICA; MICB; Mouth neoplasms; RT PCR

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; BETEL NUT; CANCER CELL CULTURE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MHC CLASS 1 CHAIN RELATED GENE A; MHC CLASS 1 CHAIN RELATED GENE B; MOUTH CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TUMOR DIFFERENTIATION;

ADULT; AGED; ARECA; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL LINE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NUTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33845747647     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00471.x     Document Type: Article

References (34)

1. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256-63.
2. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma: 2. Chromosomal aberrations. Oral Oncol 2000; 36: 311-27.
3. Maitland NJ, Cox MF, Lynas C et al. Detection of human papillomavirus DNA in biopsies of human oral tissue. Br J Cancer 1987; 56: 245-50.
4. Yeudall WA, Campo MS. Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol 1991; 72: 173-6.
5. Balaram P, Meenattoor G. Immunology of oral cancer - a review. Singapore Dent J 1996; 21: 36-41.
6. Chang KW, Kao SY, Tzeng RJ et al. Multiple molecular alterations of FHIT in betel-associated oral carcinoma. J Pathol 2002; 196: 300-6.
7. Matchin AA, Smoliagin AI. A comparative evaluation of the immune status of patients with squamous cell cancer of the oral mucosa at different stages of combined treatment. Stomatologiia (Mosk) 2000; 79: 29-32.
8. Liu CJ, Wong YK, Chang KW et al. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 2005; 34: 608-12.
9. Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970; 13: 1-27.
10. Flynn S, Stockinger B. Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation. Blood 2003; 101: 4472-8.
11. Houck JR, Romano PJ, Bartholomew M et al. Do histocompatibility antigens influence the risk of head and neck carcinoma? Cancer 1992; 69: 2327-32.
12. de Vries N, Drexhage HA, de Waal LP, de Lange G, Snow GB. Human leukocyte antigens and immunoglobulin allotypes in head and neck cancer patients with and without multiple primary tumors. Cancer 1987; 60: 957-61.
13. Koldovsky P, Haas I, Bier H, Ganzer U. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases. Eur Arch Otorhinolaryngol 1995; 252: 359-65.
14. Slootweg PJ, de Pagter M, de Weger RA, de Wilde PC. Lymphocytes at tumor margins in patients with head and neck cancer. Relationship with tumor size, human lymphocyte antigen molecules, and metastasis. Int J Oral Maxillofac Surg 1994; 23: 286-9.
15. Feenstra M, Veltkamp M, van Kuik J et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 1999; 54: 235-45.
16. Lutz CT, Kurago ZB. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. Cancer Res 1999; 59: 5793-9.
17. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994; 91: 6259-63.
18. Bahram S, Spies T. The MIC gene family. Res Immunol 1996; 147: 328-33.
19. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998; 279: 1737-40.
20. Bahram S, Spies T. Nucleotide sequence of a human MHC class I MICB cDNA. Immunogenetics 1996; 43: 230-3.
21. Bahram S, Mizuki N, Inoko H, Spies T. Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics 1996; 44: 80-1.
22. Liu CJ, Lee YJ, Chang KW et al. Polymorphism of the MICA gene and risk for oral submucous fibrosis. J Oral Pathol Med 2004; 33: 1-6.
23. Liu CJ, Lee YJ, Liu HF et al. The increase in the frequency of MICA gene A6 allele in oral squamous cell carcinoma. J Oral Pathol Med 2002; 31: 323-8.
24. Groh V, Bahram S, Bauer S et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996; 93: 12445-50.
25. Wu J, Song Y, Bakker AB et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999; 285: 730-2.
26. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-9.
27. Kriegeskorte AK, Gebhardt FE, Porcellini S et al. NKG2D-independent suppression of T cell proliferation by H60 and MICA. Proc Natl Acad Sci U S A 2005; 102: 11805-10.
28. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419: 734-8.
29. Lin SC, Liu CJ, Chiu CP et al. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med 2004; 33: 79-86.
30. Pende D, Rivera P, Marcenaro S et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 2002; 62: 6178-86.
31. Jinushi M, Takehara T, Tatsumi T et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 2003; 104: 354-61.
32. Sinor PN, Gupta PC, Murti PR et al. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 1990; 19: 94-8.
33. Gupta PC, Hebert JR, Bhonsle RB et al. Dietary factors in oral leukoplakia and submucous fibrosis in a population-based case control study in Gujarat, India. Oral Dis 1998; 4: 200-6.
34. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 1994; 23: 65-9.